Výsledky vyhledávání

Akademický článek

Synthesis and Bioactivity of N-(4-Chlorophenyl)-4-Methoxy-3-(Methylamino) Benzamide as a Potential Anti-HBV Agent

Autor: Cui AL, Sun WF, Zhong ZJ, Jin J, Xue ST, Wu S, Li YH, Li ZR

Publikováno v: Drug Design, Development and Therapy, Vol Volume 14, Pp 3723-3729 (2020)

A-Long Cui,1,* Wen-Fang Sun,1,2,* Zhao-Jin Zhong,1 Jie Jin,1 Si-Tu Xue,1 Shuo Wu,1,2 Yu-Huan Li,1,2 Zhuo-Rong Li1 1Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, People’s

Externí odkaz: https://doaj.org/article/c9e94f2a573f4589b9f89cadf1a44699

Zobrazit plný text záznamu

Akademický článek

The hydroxypropyl–β-cyclodextrin complexation of toltrazuril for enhancing bioavailability

Autor: Zhang L, Liu MX, Lu CC, Ren DD, Fan GQ, Liu C, Liu MJ, Shu G, Peng GN, Yuan ZX, Zhong ZJ, Zhang W, Fu HL

Publikováno v: Drug Design, Development and Therapy, Vol Volume 12, Pp 583-589 (2018)

Li Zhang,1,2,* Mengxi Liu,1,* Chaocheng Lu,1 Dandan Ren,1 Guoqing Fan,1 Chang Liu,1 Mengjiao Liu,1 Gang Shu,1 Guangneng Peng,1 Zhixiang Yuan,1 Zhijun Zhong,1 Wei Zhang,1 Hualin Fu1 1Department of Pharmacy, College of Veterinary Medicine, Sichuan Agri

Externí odkaz: https://doaj.org/article/f84dfd220da7419ba904eca7e2d1827e

Zobrazit plný text záznamu

Tumor heterogeneity in the recurrence of epithelial ovarian cancer demonstrated by polycomb group proteins

Autor: Gui T, Bai HM, Zeng JF, Zhong ZJ, Cao DY, Cui QC, Chen J, Yang JX, Shen K

Publikováno v: OncoTargets and Therapy, Vol 2014, Iss default, Pp 1705-1716 (2014)

Ting Gui,1,* Huimin Bai,1,* Jianfang Zeng,1 Zhaoji Zhong,1 Dongyan Cao,1 Quancai Cui,2 Jie Chen,2 Jiaxin Yang,1 Keng Shen11Department of Obstetrics and Gynecology, 2Department of Pathology, Peking Union Medical College Hospital, Peking Union Medical

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doajarticles::4a773c785ced33d2db5f30b679c411eb
http://www.dovepress.com/tumor-heterogeneity-in-the-recurrence-of-epithelial-ovarian-cancer-dem-peer-reviewed-article-OTT

Zobrazit plný text záznamu

Effects of belimumab, a B lymphocyte stimulator-specific inhibitor, on disease activity across multiple organ domains in patients with systemic lupus erythematosus: combined results from two phase III trials

Autor: Manzi, S, Sánchez Guerrero, J, Merrill, Jt, Furie, R, Gladman, D, Navarra, Sv, Ginzler, Em, D'Cruz, Dp, Doria, Andrea, Cooper, S, Zhong, Zj, Hough, D, Freimuth, W, Petri, Ma, on behalf of the BLISS 52, BLISS 76 Study Groups

Publikováno v: Annals of the Rheumatic Diseases

ObjectiveTo evaluate the effects of belimumab versus placebo, plus standard systemic lupus erythematosus (SLE) therapy, on organ domain-specific SLE disease activity.MethodsData obtained after 52 weeks of treatment from two phase III trials (BLISS-52

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6c654faa6d413054daf78b82163cc505
https://pubmed.ncbi.nlm.nih.gov/22550315

Zobrazit plný text záznamu